Pure Global

Rifu-angioconstrictin conversion/assay reagent - Taiwan Registration 4e83a24ce9d6d451b57ebd9222b6a696

Access comprehensive regulatory information for Rifu-angioconstrictin conversion/assay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 4e83a24ce9d6d451b57ebd9222b6a696 and manufactured by FUJIREBIO INC., HACHIOJI FACILITY. The authorized representative in Taiwan is Taiwan Fu Pharmaceutical Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
4e83a24ce9d6d451b57ebd9222b6a696
Registration Details
Taiwan FDA Registration: 4e83a24ce9d6d451b57ebd9222b6a696
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Rifu-angioconstrictin conversion/assay reagent
TW: ๆ—ฅๅฏŒ-่ก€็ฎกๆ”ถ็ธฎ็ด ่ฝ‰ๆ›/ๆชข้ฉ—่ฉฆๅŠ‘
Risk Class 2
Cancelled

Registration Details

4e83a24ce9d6d451b57ebd9222b6a696

DHA00601537001

Company Information

Product Details

ๆชขๆธฌไบบ่ก€ๆธ…ไธญไน‹่ก€็ฎกๆ”ถ็ธฎ็ด ่ฝ‰ๆ›? [Angiotensin Converting Enzyme (ACE)].

A Clinical chemistry and clinical toxicology

A.1090 Vasopressin-converting enzyme testing system

import

Dates and Status

Dec 09, 2005

Dec 09, 2025

Oct 28, 2022

Cancellation Information

Logged out

ๅ…ฌๅธๆญ‡ๆฅญ